For years, obesity was often misunderstood as a personal shortcoming and something people were told to fix through willpower alone
Based on your progress and comfort level with the medication, we can adjust your dosage if necessary
"The lack of standardized production and FDA oversight makes it difficult to assess the consistency and potency of oral formulations," explains Dr
Under US law, compounding pharmacies can make and sell patent-protected drugs that are on the FDA's shortages list in limited amounts, and have been reaping the rewards of supplying versions of Novo Nordisk's obesity drug Wegovy and Ozempic for diabetes, which are both based on the GLP-1 receptor agonist
Approved base, lower sourcing risk
When plasma glucose levels are low, GLP-1RAs do not stimulate insulin secretion, which helps to maintain glycemic control while also reducing the risk of hypoglycemia [3, 4]